News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
-
Dec 2, 2019
Quest Diagnostics Acquires the Clinical Laboratory Services of Boston Clinical Laboratories in Massachusetts SECAUCUS, N.J. -- December 2, 2019 — Quest Diagnostics (NYSE:DGX), the world’s...
-
Nov 20, 2019
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share,...
-
Nov 14, 2019Other Company Research Demonstrates the Value of Diagnostic Insights in Early Cardiovascular Disease Detection in Clinical and Workplace Settings
A laboratory test that evaluates high-density lipoprotein (HDL) cholesterol function provides unique and novel information for assessing cardiovascular disease risk, according to data presented...
-
Nov 5, 2019
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2019 Workplace...
-
Oct 22, 2019- Third quarter revenues of $1.96 billion, up 3.5% from 2018
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2019. "We...
-
Oct 16, 2019First-of-its-kind study shows nearly three in four physicians trust their patients to take controlled substances as prescribed, yet half of all patient test results show misuse of these drugs
Most primary care physicians (62%) fear the opioid drug crisis will be traded for a new prescription drug crisis and nearly three quarters (72%) worry that chronic pain patients will turn to...
-
Oct 4, 2019
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2019 results on Tuesday, October 22, 2019,...
-
Sep 19, 2019Quest Diagnostics Recognized for Offering One of the Nation's Best Workforce Health and Well-being Initiatives
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received the 2019 Best Employers: Excellence in Health & Well-Being...
Sep 12, 2019Strategic collaboration aims to improve patient care and reduce costs across thousands of health systems nationwide by delivering insights that empower optimal lab testingQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and hc1, the bioinformatics leader in precision testing, today unveiled Quest® Lab Stewardship™...
Sep 11, 2019Retail industry tops list with highest overall positivity rate for four consecutive yearsOne third of U.S. industry sectors experienced year-over-year double-digit increases in workforce drug positivity between 2015 and 2018, according to a new analysis of industry-specific data by...
Sep 10, 2019Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that Manuel O. Méndez has been named Senior Vice President and Chief Commercial...
-
Aug 28, 2019
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare...
-
Aug 23, 2019
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Baird 2019 Global Healthcare Conference...
-
Aug 15, 2019
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share,...
-
Jul 23, 2019- Second quarter revenues of $1.95 billion, up 1.8% from 2018
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2019. "Our...
-
Jul 18, 2019Two new companies join the GDN, expanding this novel worldwide network of leading diagnostics service providers
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the expansion of the Global Diagnostics Network (GDN), a strategic working group of...
Jul 17, 2019Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has been named to the 2019 Disability Equality Index (DEI) "Best Places to Work...
Jul 17, 2019Catholic Health Services (CHS), an integrated health care delivery system with a 24% market share on Long Island, is teaming up with Quest Diagnostics (NYSE: DGX), the world's leading provider of...
-
Jul 9, 2019
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2019 results on Tuesday, July 23, 2019,...
-
Jul 9, 2019Available Nationwide, New Service Connects Consumers with Medical-Grade Testing and Access to Physician Oversight, Counsel and Prescription Therapy When Appropriate
SECAUCUS, NJ, July 9, 2019 -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today launched a new Lyme Disease test offering that individuals can...
-
Jul 9, 2019
SECAUCUS, N.J. and EDEN PRAIRIE, Minn. (July 9, 2019) – As recently reported in numerous media outlets, on May 14, 2019, Retrieval-Masters Creditors Bureau, Inc./American Medical Collection...
-
Jun 17, 2019Participants decreased diabetes risk by 2.8 percent on average and 31 percent lost five percent or more of body weight after completing at least nine lessons in program
Individuals with prediabetes who participate in an employer-sponsored digital diabetes-prevention counseling program may reduce their risk of developing type 2 diabetes (T2D) for up to eight...
-
Jun 5, 2019
American Medical Collection Agency (AMCA), a collection agency, has disclosed that an unauthorized user had access to AMCA’s system between August 1, 2018, and March 30, 2019.
-
Jun 3, 2019
American Medical Collection Agency (AMCA), a billing collections service provider, has informed Quest Diagnostics that an unauthorized user had access to AMCA’s system containing personal...
-
May 29, 2019As the leader in Advanced Diagnostics, including Next Generation Sequencing (NGS), Quest joins a select group of commercial and academic laboratories to meet the rigorous requirements for participation in this clinical trial
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced it is participating as a designated laboratory in the NCI-Molecular Analysis for Therapy...